Landmark Renal Trials is made and published by
MOHAMMAD RABIUL I RONY.
AppBrain is an independent app data site and isn't affiliated with MOHAMMAD RABIUL I RONY.
The app name, icon, screenshots and description belong to MOHAMMAD RABIUL I RONY and are shown as
published on the App Store.
About Landmark Renal Trials
Landmark Renal Trials is a medical app developed by MOHAMMAD RABIUL I RONY.
User Ratings
The app has no ratings yet.
App Information
Landmark Renal Trials is freely available from the App Store. The app size is 3.41 MB. The latest version available is 1.7.4. The last update was on September 20, 2026.
Technical Requirements
The app has a content rating of High Maturity. The app has been available on the App Store since May 2026.
Description by MOHAMMAD RABIUL I RONY(from the App Store)
Landmark Renal Trials & Guidelines
The essential nephrology reference for clinicians, trainees and students. Every landmark trial and major guideline you need — organised, searchable and always available offline.
DESIGNED FOR HEALTHCARE PROFESSIONALS A fast, distraction-free reference for the ward round, the clinic and exam revision. No account, no sign-in, no internet connection required.
200+ LANDMARK CLINICAL TRIALS From DAPA-CKD and EMPA-KIDNEY to PIVOTAL, PEXIVAS, ADVOCATE and CONVINCE — each trial summarised with its design, key results and the practice it changed. Browse by category, filter by guideline and compare trials side by side.
MAJOR GUIDELINES, DISTILLED Key recommendations and bedside practice points from the bodies that matter: • KDIGO • KDOQI (NKF) • UKKA (UK Kidney Association) • ISPD • BTS (British Transplantation Society) • NICE • AHA Every chapter gives you graded recommendations, a plain-language summary and practical take-home points.
BUILT FOR SPEED • Instant search across trials and guidelines • Filter by topic — CKD, dialysis, transplantation, glomerular disease, anaemia, hypertension and more • Compare any two trials at a glance • Light and dark mode • Fully offline — everything lives on your device
TOPICS COVERED CKD detection and progression, SGLT2 inhibitors, MRAs and novel agents, anaemia, CKD-MBD, haemodialysis and peritoneal dialysis, vascular access, IgA nephropathy, membranous nephropathy, ANCA vasculitis, lupus nephritis, FSGS, transplantation and immunosuppression, hyperkalaemia, AKI, pregnancy in CKD and much more.
Landmark Renal Trials turns the evidence base of modern nephrology into a reference you can actually use in seconds.
Disclaimer: This app is an educational reference for healthcare professionals and students. It is not a substitute for clinical judgement, local protocols or the original guideline and trial publications. Always verify against primary sources before making clinical decisions.
Each subscription will automatically renew 3 days before the expiration date for
the same time period. Subscriptions can be cancelled at any time before the renewal.